Clinical trials · Los Angeles, CA
Exocrine Pancreatic Insufficiency clinical trials in Los Angeles
We’re tracking 3 recruiting exocrine pancreatic insufficiency studies with a site in or near Los Angeles — including Phase 2 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Los Angeles
- NCT06477159RecruitingPhase 4
Enzyme replacement for acute pancreatitis recovery
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
Los Angeles, CaliforniaAges 18 years+ - NCT07450547RecruitingPhase 2
A trial of a new medicine for cystic fibrosis and pancreatic problems
This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.
Los Angeles, CaliforniaAges 12 years+ - NCT06651580Recruiting
Gene study for kids with pancreas problems
This study collects samples like blood or tissue from children with pancreatitis to look for gene changes that might raise their risk. It helps doctors learn more about why some children get pancreas inflammation.
Los Angeles, CaliforniaAges Up to 17 years
Hear when a new Exocrine Pancreatic Insufficiency trial opens near Los Angeles, CA
We’ll email you when one opens near Los Angeles, CA — at most once a week, no account needed, unsubscribe anytime.
Exocrine Pancreatic Insufficiency trials in other cities
Where these studies are running near Los Angeles
Institutions with a site for the recruiting exocrine pancreatic insufficiency studies listed above.
- Cedars-Sinai Medical Center
- Children's Hospital Los Angeles
- Keck Medical Center of USC
- Long Beach Memorial Medical Center
- University of Southern California
What taking part in a exocrine pancreatic insufficiency study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting exocrine pancreatic insufficiency studies in California.
Common questions
- Are there exocrine pancreatic insufficiency clinical trials near Los Angeles?
- Yes. We're currently tracking 3 recruiting exocrine pancreatic insufficiency studies with a site near Los Angeles, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a exocrine pancreatic insufficiency study near Los Angeles?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Los Angeles to take part?
- Not necessarily. These studies have a site near Los Angeles, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a exocrine pancreatic insufficiency trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New exocrine pancreatic insufficiency studies open near Los Angeles regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.